Association of non-insulin-based insulin resistance indices with disease severity and adverse outcome in idiopathic pulmonary arterial hypertension: a multi-center cohort study
Authors:
Open Access
- 3 May 2024
- journal article
- research article
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 23 (1) , 1-15
Abstract
Background: Insulin resistance (IR) plays an important role in the pathophysiology of cardiovascular disease. Recent studies have shown that diabetes mellitus and impaired lipid metabolism are associated with the severity and prognosis of idiopathic pulmonary arterial hypertension (IPAH). However, the relationship between IR and pulmonary hypertension is poorly understood. This study explored the association between four IR indices and IPAH using data from a multicenter cohort. Methods: A total of 602 consecutive participants with IPAH were included in this study between January 2015 and December 2022. The metabolic score for IR (METS-IR), triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio, triglyceride and glucose (TyG) index, and triglyceride-glucose-body mass index (TyG-BMI) were used to quantify IR levels in patients with IPAH. The correlation between non-insulin-based IR indices and long-term adverse outcomes was determined using multivariate Cox regression models and restricted cubic splines. Results: During a mean of 3.6 years’ follow-up, 214 participants experienced all-cause death or worsening condition. Compared with in low to intermediate-low risk patients, the TG/HDL-C ratio (2.9 ± 1.7 vs. 3.3 ± 2.1, P = 0.003) and METS-IR (34.5 ± 6.7 vs. 36.4 ± 7.5, P < 0.001) were significantly increased in high to intermediate-high risk patients. IR indices correlated with well-validated variables that reflected the severity of IPAH, such as the cardiac index and stroke volume index. Multivariate Cox regression analyses indicated that the TyG-BMI index (hazard ratio [HR] 1.179, 95% confidence interval [CI] 1.020, 1.363 per 1.0-standard deviation [SD] increment, P = 0.026) and METS-IR (HR 1.169, 95% CI 1.016, 1.345 per 1.0-SD increment, P = 0.030) independently predicted adverse outcomes. Addition of the TG/HDL-C ratio and METS-IR significantly improved the reclassification and discrimination ability beyond the European Society of Cardiology (ESC) risk score. Conclusions: IR is associated with the severity and long-term prognosis of IPAH. TyG-BMI and METS-IR can independently predict clinical worsening events, while METS-IR also provide incremental predictive performance beyond the ESC risk stratification.Keywords
Funding Information
- National High Level Hospital Clinical Research Funding (2022-GSP-GG-35)
- CAMS Innovation Fund for Medical Sciences (2020-I2M-C&T-B-055, 2021-I2M-C&T-B-032)
- “Double First-Class” Discipline Construction Fund of Peking Union Medical College and Chinese Academy of Medical Sciences (2019E-XK04-02)
- The Capital's Funds for Health Improvement and Research (2020-2-4033, 2020‐4‐4035)
This publication has 64 references indexed in Scilit:
- Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysisThe Journal of Heart and Lung Transplantation, 2022
- Prevalence and clinical significance of conduction disease in patients with idiopathic pulmonary arterial hypertensionThe Journal of Heart and Lung Transplantation, 2022
- Association Between BMI and Obesity With Survival in Pulmonary Arterial HypertensionChest, 2018
- Diabetes Mellitus Associates with Increased Right Ventricular Afterload and Remodeling in Pulmonary Arterial HypertensionThe American Journal of Medicine, 2018
- TG/HDL-C ratio and visceral adiposity index may be useful in assessment of insulin resistance in adults with type 1 diabetes in clinical practiceJournal of Clinical Lipidology, 2018
- Impact of insulin resistance on ventricular function in pulmonary arterial hypertensionThe Journal of Heart and Lung Transplantation, 2014
- Role of microangiopathy in diabetic cardiomyopathyHeart Failure Reviews, 2013
- HbA1c in pulmonary arterial hypertension: A marker of prognostic relevance?The Journal of Heart and Lung Transplantation, 2012
- PPARγ and the Pathobiology of Pulmonary Arterial Hypertension2009
- Magnitude and implications of spontaneous hemodynamic variability in primary pulmonary hypertensionThe American Journal of Cardiology, 1985